The molecular mechanisms of pain associated with alphaherpesvirus latency are not 2 clear. We hypothesize that the voltage-gated sodium channels (VGSC) on dorsal root 3 ganglion (DRG) neurons controlling electrical impulses may have abnormal activity during 4 viral latent infection and reactivation. We used HSV-1 to infect human DRG-derived 5 neuronal cell line HD10.6 to study viral latency establishment, maintenance and 6 reactivation as well as changes of VGSC functional expression. Differentiated cells 7 exhibited robust tetrodotoxin (TTX) sensitive sodium currents and acute infection 8 significantly reduced the VGSC functional expression within 24 hours, and completely 9 abolished the VGSC activity within three days lytic infection. A quiescent state of infection 10 mimicking latency can be achieved by HSV infection in the presence of acyclovir (ACV) 11 for 7 days followed by 5 days of ACV washout and the viruses can remain dormant for 12 another three weeks. It was noted that during HSV-1 latency establishment, the loss of 13 VGSC activity caused by HSV-1 infection could not be blocked by ACV treatment within 14 3 days infection. However, neurons with continued treatment of ACV for another 4 days 15 showed a gradual recovery of VGSC functional expression. Furthermore, the latent 16 neurons exhibited higher VGSC activity in comparison to controls. The overall regulation 17 of VGSC by HSV-1 during its quiescent infection was proved by increased transcription 18 and possible translation of Nav1.7. Together these observations demonstrated a very 19 complex pattern of electrophysiological changes during HSV infection of DRG neurons, 20 which may have implication for understanding the mechanisms of virus-mediated pain 21 linked to latency and reactivation.
Introduction

12
HSV-1 is a neurotropic pathogen associated with excruciating orofacial 13 sensation and other chronic neuropathic pains (1) (2) (3) (4) (5) (6) (7) (8) (9) . After the acute infection, the virus the sensory abnormalities described in patients suffering orofacial chronic pain 1 associated with HSV-1 infection. cells were infected at moi of 1 in the absence or presence of ACV followed by fluorescent 8 microscopy to monitor the progress of viral infection. The results showed that without ACV 9 HD10.6 cells were well-infected by McKrae/GFP and replicated efficiently at 3 dpi 10 (compare Fig. 1A and B ). In the presence of ACV, fluorescent microscopy indicated that 11 approximately 60% of the cells were infected at 3 dpi but replication was significantly 12 decreased as evidenced by the weak green fluorescence (Fig. 1C ). The green 13 fluorescence continued to decrease at 7 dpi ( Fig. 1D ) and was barely detected at 12 dpi 14 after 5 days of ACV washout (Fig. 1E ). This quiescent state of infection, found in 15 approximately all of the infected cells, can be maintained for another two weeks without 16 evidence of viral replication (data not shown). These quiescently infected cells, 17 nonetheless, displayed significantly increased green fluorescence after adding the HDAC 18 inhibitor TSA for 2 days (Fig. 1F ). These findings suggested that differentiated HD10.6 19 cells were able to support HSV-1 infection in a dormant state mimicking latency and 20 maintain the capacity to be rebooted to replicate similar to reactivation. TSA increased viral gene expression and replication but no virus release. The effect of 1 TSA was further analyzed by qRTPCR to investigate changes in viral gene expression. 2 The results showed that HSV-1 TK and GFP under the control of CMV promoter were 3 increased 3.47-fold and 124-fold by TSA, respectively, following reactivation ( Fig. 2A and   4 B). The PI3K inhibitor LY294002, which was used to induce HSV-1 reactivation (23-25), 5 did not appear to increase the viral gene expression, probably due to the fact that 6 neurotrophins such as NGF and GDNF were not removed ( Fig. 2A and B) . The release 7 of infectious viral particles was tested by collecting media of infected HD10.6 cultures, 8 followed by plaque assays. Neither the TSA nor the LY294002 treatment was able to 9 trigger the release of viral particles (data not shown). The same experiment was 10 performed using the infected HD10.6 cell lysate and the results indicated that TSA 11 treatment produced a virus titer approximately 32 pfu/ml, while the latent cells and cells 12 under LY294002 treatment generated no plaque (Fig. 2C ). These results indicated that 13 HDAC inhibitor TSA promoted viral gene expression and replication of the latent HD10.6 14 cells but the viral egress was impaired. were treated with 100 μM ACV for 7 days to initiate the formation of HSV-1 quiescent 20 infection. For latency maintenance (LM), ACV was then removed to continue the dormant 21 state of infection for 3 days. The reactivation was attempted by adding 1µM TSA for 2 22 days. Transcription of the viral genes ICP0, TK, and LAT in the absence and presence of 23 7 ACV at different time points (3dpi, 7dpi, and 12dpi) was analyzed by qRTPCR. It was 1 shown that, compared to lytic infection, ICP0 and TK decreased 50% and 75% at 3dpi in 2 the presence of ACV, respectively ( Fig. 3B ). LAT, on the other hand, increased and 3 accumulated to a comparable level at 3dpi without viral replication ( Fig. 3B ). All three viral 4 transcripts, nonetheless, declined at 7dpi and 12dpi but TSA reversed the diminishing 5 trend with significant increase (Fig. 3B ). Collectively these results suggested that 6 differentiated HD10.6 supported the establishment of HSV-1 quiescent infection thus 7 mimicking the maintenance of latency. TSA treatment overturned the dormant state, 8 increased the viral gene expression, and promoted replication. LAT did not accumulate 9 when the virus established latency in vitro but was relatively abundant temporarily at 3dpi 10 without viral replication.
Na + channel activity is abolished by HSV-1 infection but gradually recovered in latently- 13 infected HD10.6. To test the impact of viral infection on sodium channel activity, 14 differentiated cells were subjected to McKrae/GFP infection followed by 15 electrophysiological recordings of Na + currents from cells expressing green fluorescence 16 as evidence of infection. VGSC activity was measured as current density, which was 17 calculated by dividing the maximal current amplitude by cell capacitance (Fig. 4A ).
18
Differentiated control cells exhibited robust sodium currents and lytic infection at 3dpi
19 eliminated the Na + currents (Fig. 4B, Lane 3) , similar to what we previously observed in 20 ND7/23 cells (26). The effects of infection in the presence of ACV on the Na + currents 21 were assessed at 3dpi and 7dpi. It can be seen that Na + currents were not affected by that TTX at 250 nM significantly reduced the Na + current. Quantitative studies showed 10 that approximately 88% of Na + current was eliminated by TTX ( Fig. 5C ), in agreement 11 with the previous finding that that HD10.6 cells primarily utilized TTX-sensitive VGSC for 12 its physiological activity (28). The expression of two TTX-sensitive channels Nav1.3 and 13 Nav1.7 was analyzed by qRTPCR and the results indicated that Nav1.7, but not Nav1. 3, 14 was steadily increased during LE ( Fig. 5D ). Together these studies suggested that lost 15 VGSC activity due to viral infection was recovered because of Nav1.7 expression during 16 LE.
17 18 Nav1.7 expression was increased in latently infected neurons. We continued to study 19 Nav1.7 based on the observation that HD10.6 cells displayed TTX-sensitive VGSC 20 activity. The expression profile of sodium channels in the latent neurons was analyzed by 21 Western blot using antibodies against the TTX-sensitive channel subunits Nav 1.7. The 22 results showed that Nav1.7 protein was expressed in control cells and higher in latent Lane 2). These results suggested that Nav1.7 protein expression was elevated in latent 5 neurons, probably due to increased transcription influenced by latent virus. Nav1.7 6 expression on individual neurons was further assessed by immunofluorescent 7 microscopy and it showed that Nav1.7 expression in the latent neurons was as high as 8 the uninfected ones if not increased (Fig. 6C ). The signal, nonetheless, became weaker 9 in neurons with viral reactivation triggered by TSA ( Fig. 6D ), suggesting viral replication 10 may have effects to reduce the Nav1.7 expression. for latent neurons, there were less than 0.02% of the cells with bright GFP, which were 23 regarded as failing to establish latency, none of our current recordings are from those 1 bright GFP cells. As for the TSA treatment, both control ( Fig. 7E ) and infected groups 2 ( Fig. 7F ) revealed charts with current density shifting toward to the left with 45-50% 3 neurons exhibiting low (<40 pA/pF) current densities, suggesting a trend of decrease 4 VGSC number and activity. Collectively these results indicated that latent neurons, 5 compared to controls, appeared to have higher VGSC activity, presumably resulting from 6 increased Nav1.7 protein expression due to increased transcription influenced by latent 7 virus. This Nav1.7 increase was nullified when reactivation occurred by TSA. However, it 8 is important to note that TSA treatment per se, though did not considerably affect the level 9 of protein expression, significantly decreased the VGSC activity as well. The glossary of viral latency and reactivation has been an interesting topic for all 13 virologists especially the ones who studied alpha herpesviruses (29). It is generally designed to target the LAT stable intron (45), it is not impossible that this accumulation 20 resulted from delayed degradation. However, we cannot rule out the possibility that HSV- 21 1 LAT may play a role in latency initiation, which warrant future studies. Our results indicated that VGSC activity in HD10.6 cells was quickly eliminated by HSV- and immunofluorescent microscopy) did not show any Nav1.3 expression (data not 1 shown). Our investigation on Nav 1.7 indicated that its transcription was active and the 2 total protein was slightly higher during latency but reduced upon TSA treatment, which 3 causes viral reactivation. Immunofluorescent microscopy revealed that latent neurons 4 under the influence of TSA displayed reduced expression of Nav1.7, suggesting that 5 neurons with latent HSV-1 exhibited an induction of Nav1.7 and reactivation impeded this 6 increase. Subsequent electrophysiological studies investigating the VGSC activity 7 demonstrated that sodium current, though higher in latent neurons and lower after 8 reactivation, it also revealed a decrease in the TSA control. Given the fact that total 9 Nav1.7 protein was not significantly decreased by TSA, it is likely that TSA modulated 
Cells and virus: 2
The human DRG neuronal cell line HD10.6 was used as an in vitro model as 3 previously described (33, 34) and a gift from Celgene Corporation (San Diego, CA).
4
African green monkey kidney Vero cells (ATCC, Cat# CCL-81) and the culture condition Acycloguanosine (acyclovir or ACV, Cat#: A4669, Sigma-Aldrich) overnight, then 20 exposed to HSV-1 for 1 h at a MOI of 1. Unbound viral particles were washed out after 21 1 h and differentiation media (DM) supplemented with 100 μM ACV was applied for 3d, 22 then changed with fresh DM with 100 μM ACV followed by culture for another 4d to The plaque assays were performed as previously described (26, 56, 57) . Briefly, the 5 cell lysates of infected HD10.6 cells were mixed with 500μl media and subjected to three 6 cycles of freeze-thaw to have virus released into the media. The cell lysates as well as 7 the supernatant from infected cultures were serially diluted before being added to Vero 8 cell monolayer in 24-well plates seeded at 8x10 4 cells/well. After 1hpi, the media were 9 removed and replaced by fresh culture media supplemented with 5% FBS. The cells 10 were fixed after 2d with ice-cold methanol and stained with crystal violet prior to counting 11 plaque formation. Data was collected from triplicates. filters, which can be used to identify the infected HD10.6 cells by the expression of GFP.
17
Voltage-activated sodium currents from individual cells was recorded using the whole-18 cell patch-clamp technique. Recordings were performed at room temperature (22-19 24ºC). The pipette electrode solution consisted of (in mM) CsCl (120), MgCl2 (2), 20 HEPES-KOH (10), EGTA (10), ATP (1), and GTP (0.1), pH 7.4 adjusted with CsOH. 21 The extracellular solution used to measure Na+ currents contained (in mM) NaCl (145), Commander was used to compensate pipette offset, whole cell capacitance, and series 5 resistance (≤10 MΩ) automatically. Sampling rates were 5 ~10 kHz. For quantitative 6 analysis, cell size was normalized as previous described (60, 61). In short, dividing the 7 recorded current amplitudes by cell capacitance, which was determined by integration 8 of the transient current evoked by a 10-mV voltage step from a holding potential of -60 9 mV. Voltage-gated Na + current density was calculated by dividing the maximal current 10 amplitude generated by a voltage step around +10mV from a holding potential of -100 11 mV by the cell capacitance. TTX was purchased from TOCRIS (Cat#: 1069).
13
Western blot analysis: 14 Immunoblot analysis of the voltage-gated Na + channel subunit Nav1.7 was conducted 15 as previously described (26), using a rabbit anti-Nav1.7 primary antibody (1:1000, Cat 16 #. ab196906, Abcam, US). Proteins were separated on pre-cast SDS-PAGE 8% gels 17 (Cat#: NW0080, ThermoFisher) and then transferred to nitrocellulose membranes using 18 the Invitrogen iBlot system. After a horseradish peroxidase-conjugated anti-rabbit 19 secondary antibody (Cat.#211-035-109, Jackson ImmunoResearch Lab, West Grove, 20 PA) incubation for 1 h at room temperature, a chemiluminescent substrate (Super 21 Signal West Pico, Cat.#34080, ThermoFisher) was applied, the signals were captured 22 using a ChemiDoc™ XRS+ documentation system (Bio-Rad, Hercules, CA). For 23 controls, membranes were stripped and reprobed with a tubulin-specific antibody 1 PubMed PMID: 14633592; PMCID: PMC1892378. 38 
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GFP under different conditions. Note the voltage-gated Na + current density was calculated 
